Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 437

Results For "MED"

5377 News Found

KOREA PACK and ICPI to be held in June 2022 in hybrid format
Packaging | December 13, 2021

KOREA PACK and ICPI to be held in June 2022 in hybrid format

KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022


Philips instals 1000 active cath labs in India
Medical Device | December 13, 2021

Philips instals 1000 active cath labs in India

Over the next few years, Philips aims to double the number of its active cath labs in India with a special focus on improving accessibility to quality cardiac and neurovascular care in tier 2 and tier 3 cities


Zydus Pharmaceuticals USA receives tentative approval for schizophrenia drug
Drug Approval | December 11, 2021

Zydus Pharmaceuticals USA receives tentative approval for schizophrenia drug

The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.


SPARC to present clinical data on vodobatinib
Biotech | December 11, 2021

SPARC to present clinical data on vodobatinib

Results from the ongoing vodobatinib clinical study are being presented for the second consecutive year at the ASH annual meeting, underlining the promising potential of the drug for the treatment of heavily pre-treated CML


Cipla aims to improve access to nebulisers in PHCs
Public Health | December 11, 2021

Cipla aims to improve access to nebulisers in PHCs

The company will donate 5000 nebulizers to primary health care centres in rural India


Alembic acquires stake in RIGlmmune
Biotech | December 11, 2021

Alembic acquires stake in RIGlmmune

The company is focused on the development of novel treatments for RNA viruses


Govt includes seven more companies under PLI scheme
News | December 10, 2021

Govt includes seven more companies under PLI scheme

Approvals accorded under Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ drug intermediates and Active Pharmaceutical Ingredients (APIs


Zydus receives  USFDA  approval for Phase2(b)/3 trial of Saroglitazar
Biotech | December 10, 2021

Zydus receives USFDA approval for Phase2(b)/3 trial of Saroglitazar

Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)


Indian government approves eight firms for PLI scheme
Medical Device | December 10, 2021

Indian government approves eight firms for PLI scheme

The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore


Dr Reddy’s launch Venlafaxine ER tablets in the US
Drug Approval | December 10, 2021

Dr Reddy’s launch Venlafaxine ER tablets in the US

The tablets are available in 150 mg and 225 mg strengths in bottle count sizes of 30 and 90.